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Abstract - General anesthesia is well known to 
offer physicians access to a broad variety of 
invasive procedures otherwise deemed too 
risky.  Anesthesia machines provides the means 
for anesthetizing patients safely in the hospital 
operating room.  However, these devices are 
increasingly unable to meet the demands and 
needs outside of the hospital.  Developing 
countries struggle to purchase and maintain 
these costly devices, leading to a 40-fold 
increase in anesthesia-related deaths compared 
to developed countries.  Small-office practices 
in the United States experience significantly 
poorer anesthesia outcomes and increased legal 
claims versus their larger hospital 
counterparts, resulting in 60% more 
anesthesia-related deaths.  Environmental 
impacts and global health concerns from the 
emitted anesthetic gases have brought into 
serious question the prevailing notion that 
unchecked emissions were sustainable.  These 
factors can all be attributed to anesthesia 
machine design and technology having the 
primary intended use in the traditional 
operating room.  The long-term goal of this 
work is to develop technologies in anesthesia 
that expand its safe use, decrease underlying 
costs, and reduce the total emissions.  The 
immediate objective of this work is to create a 
feedback-controlled anesthetic gas vaporizer-
scavenger system and evaluate its performance.  
The central hypothesis is that the combined use 
of mesoporous materials and feedback control 
provide the opportunity for repeatable capture 
and release of expired anesthetic gases during 
anesthesia delivery.  Our rationale is that such 
a device will help reduce the amount of 
anesthetic needed while simultaneously offering 
improved control over the delivery of anesthetic 
gases.   
I. INTRODUCTION 
 
Anesthesia is a critical component of most surgical 
procedures.  General anesthetics cause patients to 
lose consciousness and sensation via suppression 
of the central nervous systems.  Anesthesiologist 
accomplish this through either intravenous agents 
or inhalational agents.  Delivery of inhalational 
agents typically necessitates the use of combined 
ventilator and agent vaporizer, simply known as an 
anesthesia machine.  Anesthesia machines have 
undergone a several major revisions in their design 
for both practical and safety reasons.  The modern 
anesthesia machine design is a variant of the Boyle 
anesthesia machine developed in 1917, with the 
core design today being identical but with the 
addition of device and patient monitoring and 
automated safety systems.1-3 
These incremental improvements on the anesthesia 
machine have yielded obvious benefits to the 
standard operating room.  Deliberate addition of 
safety features combined with integrated patient 
monitoring has led the field of anesthesia from one 
of the riskier fields in medicine to one of the safer, 
with 1 in 1,000 deaths in the 1940s, 1 in 10,000 in 
the 1970s, and finally 1 in 100,000 by the turn of 
the century.4–7  However, these improvements are 
not without their unaddressed problems.  Access to 
proper anesthetic care on a global scale remains 
shockingly low, with 5 billion individuals having 
inadequate or no access.8  On a more local basis, 
the expansion of anesthesia delivered in small-
office practices as led to a sudden increase in 
preventable complications.9–11  Last, the emission 
of these inhalational agents is becoming an 
increasing concern as the direct and indirect 
environmental impact is being better understood 
and quantified.12–16 Inherently these issues are 
multi-faceted, however they can in large part be 
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attributed to the current design of the anesthesia 
machine. 
These factors are the basis for identifying and 
improving a variety of components of the 
anesthesia machine to ultimately expand the areas 
of use and reduces the negative impacts imposed 
by inhalational agent emissions.  It is the goal of 
this dissertation to broaden the body of knowledge 
related to inhalational agent monitoring, reversible 
inhalational capture, and design and modelling of 
these systems. 
 
II. ISSUES IN ANESTHESIA 
 
Alongside the need for patient monitoring, the 
ability to safely scavenge expired anesthetic gases 
from the anesthesia machine and away from 
clinicians remains another hurdle outside of the 
hospital.17,19,20  This hurdle again encourages the 
use of TIVA over inhalational anesthetics at both 
increased financial cost and risk of undetected 
respiratory depression.18  Even with appropriate 
anesthetic scavenging or respiratory monitoring, a 
secondary impact of inhalational anesthetics is the 
negative environmental impact.13–15  Because the 
three primary volatile anesthetics (isoflurane, 
sevoflurane, and desflurane) undergo negligible 
metabolism in vivo, they are largely exhaled and 
subsequently scavenged and vented by anesthesia 
machines to hospital waste gas systems which 
release these gases to the atmosphere.   Studies 
have estimated that inhaled anesthetic gases 
contribute upwards of two-thirds of surgical 
procedure greenhouse gas emissions and 98% of 
the ozone depleting compounds.16  While not a 
direct impact to the patient in the operating room, 
further studies estimate that greenhouse gas 
emissions associated with US health care activities 
cause the loss of 123,000-381,000 disability-
adjusted life-years annually, well exceeding the 
44,000-98,000 who die annual due to preventable 
medical errors.15  In anesthesia, volatile agent 
release marks the primary environmental burden 
and are therefore the highest priority for reduction. 
1.3 Current Design of Anesthesia Machine 
A detailed understanding of the anesthesia 
machine is needed to identify and address the 
shortcomings associated with current delivery of 
anesthesia and will therefore be reviewed.  In the 
most basic sense, the primary role of the anesthesia 
machine is to deliver fresh oxygen and anesthetic 
gases to patients during surgery and 
simultaneously remove exhaled carbon dioxide.  
This process can be broken down into two sections 
of the machine: high-pressure and low-pressure 
(Figure 1).  The high-pressure portion of the 
machine begins with oxygen, air, and nitrous oxide 
entering the machine from either a hospital 
supplied pipeline or a gas cylinder.  Pressure 
regulators drop the pressure down to 
approximately 50 psi.  A junction is placed 
between the nitrous oxide and oxygen lines to fit a 
fail-safe valve.  This valve ensures that nitrous 
oxide will only flow if there is adequate pressure 
in the oxygen line, a first step in preventing the 
accidental delivery of hypoxic mixtures to patients 
in the event of an oxygen line failure.  In tandem 
with this fail-safe valve, a pressure sensor is often 
affixed to the oxygen line to additionally alarm in 
the event of a sudden pressure drop.  Moving 
farther downstream, variable flow control valves 
allow the clinician to determine the amount of 
fresh gas entering the vaporizers.  Older model 
anesthesia machines incorporated a coupling chain 
between the oxygen and nitrous oxide lines to 
ensure again that a clinician does not erroneously 
deliver hypoxic mixtures.  More modern 
anesthesia machines accomplish this through 
computer monitored controls, albeit with 
limitations and still concern for accidental 
generation of hypoxic conditions.21  
As fresh gas moves into the low-pressure leg of the 
system, it pass through an anesthetic vaporizer.  
Modern vaporizers are typically variable-bypass 
vaporizers.  These function by allowing a small 
amount of fresh gas to by bypassed through a tank 
filled with the volatile anesthetics.  Control over 
the final concentration is determined by how much 
fresh gas is bypassed through the tank.  Because 
the vapor pressure of each volatile anesthetic is 
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different, each vaporizer is carefully calibrated for 
each specific anesthetic agent.  Advanced 
vaporizers additionally utilize an expansion rod 
that will further vary the bypass of flow as 
temperatures change.  
This anesthetic rich gas now enters one of three 
breathing circuit configurations: open, semi-
closed/semi-open, or closed.  In an open breathing 
circuit, also known as Mapleson breathing circuit, 
anesthetic rich gas is delivered to the patient at 
inspiration, with an adjustable pressure limiting 
(APL) valve then immediately removing the gas to 
a waste stream during exhalation.  Open breathing 
circuits are the simplest of breathing circuits, 
however, fail to reuse any of the exhaled volatile 
anesthetic gas.  Semi-closed/semi-open breathing 
circuits partially address this by recirculating 
exhaled volatile anesthetic back into the 
inspiratory limb.  However, this necessitates the 
addition of a carbon dioxide scrubber to avoid 
Figure 1 - Schematic of gas flow in a standard anesthesia machine, including gas delivery, common patient breathing circuits, and waste 
anesthetic gas scavenging. 
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hypercapnia.  These breathing circuits still waste 
anesthetic rich gas at the same rate is the incoming 
fresh gas flow.  The differentiation between semi-
closed and semi-open is based on the fresh gas 
flows and subsequently the amount of rebreathing.  
Semi-closed systems have lower fresh gas flow 
with some rebreathing, while semi-open systems 
have higher fresh gas flow and little to no 
rebreathing.  Fully closed systems have fresh gas 
flows that equally match the patient uptake, 
requiring no addition of a waste stream.  This 
necessitates diligent patient vitals monitoring to 
match physiologic needs as well as difficulty in 
accurately titrating the correct inspired anesthetic 
gas concentration. 
The ventilator that drives the gas coming from the 
anesthesia machine can exists in a variety of 
locations in the breathing circuit.  Mechanical 
ventilation methods range from spontaneous 
respiratory support to complete machine support; 
however, all ventilators function by increasing the 
pressure inside the inspiratory limb periodically to 
facilitate fresh gas entering the lungs.  At the 
junction of the inspiratory and expiratory limb, 
also known as the Y-piece, gas is sampled to 
monitor respiratory gases such as oxygen and 
carbon dioxide as well as anesthetic gases 
including nitrous oxide and volatile anesthetic 
agents.  Respiratory flow is also monitored at 
either the Y-piece or through the ventilator to 
ensure proper ventilation.22  
 
III. Reduction of Anesthetic Gas Emissions 
 
Anthropogenic caused climate change has been 
receiving a distinct increase in attention from both 
the public and at research institutions.  Carbon 
dioxide remains the main player in greenhouse gas 
contribution, representing more than 76% of the 
total greenhouse gas emissions, primarily from 
fossil fuel combustion.  Fluorinated hydrocarbons, 
the category of molecules that volatile anesthetic 
gases fall under, represent a much smaller fraction 
of greenhouse gas emissions, representing only 2% 
of the total volume.  However, due to the chemical 
stability of these molecules and subsequent long 
half-life, most of these gases possess a higher 
global warming potential compared to carbon 
dioxide and impose a significant impact on climate 
change.23  
Waste volatile anesthetic gases have little to no 
economic value and are therefore vented from the 
hospital directly into the atmosphere.  
Consequentially, several technologies have been 
proposed or developed to remove these 
compounds, including adsorption, absorption, 
condensation, membrane separation, or 
decomposition processing.  Of these technologies, 
adsorption and absorption technologies have seen 
the most application, in part due to the high 
operating and capital costs of the other described 
methods.  Despite developments in adsorptive and 
absorptive methods for capture and regeneration of 
waste volatile anesthetic gases, the field remains in 
its infancy.  Few publications exist that describe 
sorption or breakthrough properties of volatile 
anesthetics with porous media, with most older 
publications focusing on volatile anesthetics that 
are no longer used.24-26  Other publications review 
methods for treating waste gases containing 
volatile organic compounds, however none of 
these publications are specific to volatile 
anesthetic emissions and considerations specific to 
that field.27  As a result, there exists a broad gap in 
knowledge for material characterizations 
describing reversable volatile anesthetic gas 
capture in both static and dynamic conditions. 
1.5.1 Principles of Gas Adsorption 
The retention or release of substances onto porous 
media, especially from a mobile (liquid or 
gaseous) to a solid phase, is a well-studied field.  
The curve that describes the retention of the 
substance onto the porous media at various 
concentrations is called the “sorption isotherm” 
and is used to predict the mass transfer of the 
substance beyond the empirical study.  This is 
described as the solute concentration of the 
compound compared to the concentration of the 
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compound on the solid particles, described as P 
and P0 respectively.  Ideally the sorption isotherm 
would be represented as time-independent 
capacity, allowing all various reactions to meet 
equilibrium. However, because many of the intra-
molecular retention and release mechanisms are 
strongly kinetically controlled on time scales 
beyond practical use, many sorption isotherms will 
specify time-dependence.27  The kinetics of these 
mechanisms can also vary drastically between 
adsorption and desorption, introducing hysteresis 
to the sorption isotherm plots.  
 
 Figure 2 - Sorption isotherm characteristics as recommended by 
IUPAC.28 
Based on commonly observed behaviors, sorption 
isotherms have been described in 6 main shapes by 
IUPAC.  These types of isotherms are 
characteristic of adsorbents that are microporous 
(Type I), microporous (Type II, III, and VI), or 
mesoporous (Types IV and V) are show in Figure 
2.28  The hysteresis found in Type IV and V are 
further classified and are shown in Figure 3.  
Within these sub-classifications, H1 is reflective of 
porous materials consisting of cylindrical pore 
channels or spherical pores.  Type H2 is reflective 
of materials with disordered pore size and shape, 
especially pore with high tortuosity within the 
pore.  Type H3 and H4 hysteresis both are 
indicative of slit-shaped pores, with H3 showing 
no limit to the adsorption at high pressure. 
 
Figure 3 - Classification of sorption isotherm hysteresis. 
Determining these types of isotherm types is 
typically done empirically but can provide further 
insight when used to determine an appropriate 
model to infer information beyond the collected 
data.  The simplest adsorption isotherm model 
describes the amount of surface adsorbate as 
directly proportional to the partial pressure of the 
gas.  The model typically only applies at relatively 
low concentrations due to the implication that 
there is no competitive behavior from one 
adsorbate molecule to another.  Thus, the 
equilibrium of the adsorbate concentrations to the 
adsorbed phase can simply be described a linear 
expression also known as Henry’s Law.29  
𝑞𝑞𝑒𝑒 = 𝐾𝐾𝐾𝐾 
Where qe is the amount of adsorbate at 
equilibrium, K is an equilibrium constant, P0 is the 
maximum tested pressure, and P is the pressure of 
interest. 
Langmuir adsorption was derived by Irving 
Langmuir to describe the gas-solid adsorption as 
well as to quantify the adsorptive capacities of 
various adsorbents.  The model also assumes 
monolayer adsorption at the surface of the 
adsorbate.  As a result, this is graphically 
represented by a Type I isotherm, whereas the sites 
for adsorption fill, the total surface capacity will be 
met and no further adsorption can take place, and 
can be expressed as the following: 
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Where Q0 is the maximum monolayer coverage 
capacity, b is the Langmuir isotherm constant, and 
Ce are the chosen equilibrium concentrations.30 
Herbert Freundlich gave provided a basis for 
modelling reversible adsorption on heterogenous 
surfaces that were additionally not restricted to the 
formation of a monolayer on the surface.  This has 
been found particularly useful for modelling 
organic compounds on activated carbon and 
molecular sieves.31  The non-linear form of the 
Freundlich isotherm can be described as: 
𝑞𝑞𝑒𝑒 =  𝐾𝐾𝐹𝐹𝐶𝐶𝑒𝑒
1 𝑛𝑛�  
Where Kf is the Freundlich isotherm constant 
related to adsorption capacity, and n is the 
adsorption intensity. 
These models provide good insight into the 
equilibrium capacity pairings of gas-solid phase 
sorption systems, however as previously 
mentioned, poses difficulty in accurately described 
the anticipated kinetics in dynamic systems.  When 
describing the sorption of an adsorbent through a 
fixed bed of adsorbate, describing and modelling 
the breakthrough curve is of primary interest.  Fast 
kinetics implies a steep breakthrough curve with 
rapid adsorption onto the surface of the adsorbate, 
while slow kinetics will lead to a distended 
breakthrough curve.  Additionally, regardless of 
any hysteresis in the sorption isotherm, the 
breakthrough behavior of adsorption versus 
desorption are widely different in almost all cases. 
Modelling of breakthrough curves requires in 
depth knowledge of the sorption isotherm, particle 
density and void fraction, kinetics, and fixed-bed 
dynamics.  Experimental data can be used to 
generate empirical models; however, care should 
be taken when making predictions as either 
conditions or materials change.  The Wheeler-
Robell equation is a simple empirically informed 
equilibrium model that has had notable success.  
The equation-based model applies to any isotherm 
form and retains simplicity by neglecting the 
impacts of axial dispersion.32 
 
II.  METHODS 
 
Sorption Isotherm of Porous Materials with 
Anesthetic gases 
Two generalized tests were performed to better 
understand the general behavior of activated 
charcoal and anesthetic gases.  The first test 
consisted of a 5 L/min flow of oxygen containing 
5% isoflurane (Piramal Healthcare Limited, 
Andhra Pradesh, India) to be passed through a 
cylindrical vessel containing 42 grams of activated 
charcoal (Oxpure 1220C-75, Oxbow Activated 
Carbon, West Palm Beach, FL) until 0.5% 
isoflurane pushed through (approximately 10 
minutes).  The vessel was sealed and weighed to 
determine the amount of anesthetic gas adsorbed 
onto the surface of the charcoal.  Next, a gas flow 
containing pure oxygen was pushed through the 
vessel at a rate of 2 L/min and the concentration of 
anesthetic gas leaving the vessel was measured.  
The same process was repeated with non-porous 
beads as a control. A second test consisted of a 
smaller vessel containing 10 grams of partially-
saturated activated charcoal (total weight of 14 
grams) placed between the Y-piece of an 
anesthesia circuit and a mechanical lung simulator 
(TTL Michigan Testlung, Michigan Instruments, 
Grand Rapids, MI).  This test lung was then driven 
using a ventilator and 100% oxygen, with the 
concentration of isoflurane between the vessel and 
test lung being monitored.  A control was 
performed with non-porous beads. 
 
 
Anesthetic Gas Scavenger-Vaporizing Device 
Test 
An initial proof-of-concept prototype was 
demonstrated and fitted within the rebreathing 
circuit of a current anesthesia.  This system 
consisted of a housing with two chambers, one 
fitted with a charcoal cartridge, and the other open 
to free gas flow.  A gear with a semicircular 
opening was actuated externally to determine 
which chamber, or combination of chambers, had 
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fresh gas traveling through from the anesthesia 
machine to the simulated lung.  In addition, 
differential pressure sensors were attached at both 
chambers to detect inhalation and exhalation.  
Anesthetic gas concentration measurements from 
a standard infrared gas bench was used for basic 
feedback control.  A microcontroller controlled the 
orientation of the gear valve to titrate the 
anesthetic concentration based on breath detection, 
anesthetic gas concentration, and a user input for 
desired anesthetic concentration using a 
rudimentary hysteresis controller. 
 
III.  RESULTS 
 
A. Sorption Isotherm of Porous Materials 
Isoflurane was released at concentrations suitable 
for anesthesia maintenance for a significant 
amount of time, approximately 10 minutes (Figure 
4).  Ventilation was also tested to investigate more 
dynamic conditions where the device was 
ventilated with a test lung (Figure 5).  Once 
saturated, the activated charcoal had absorbed 
approximately 60% of its total weight in isoflurane 
and was capable of repeatedly reflecting 10% of its 
total weight in isoflurane or about 3.2 mL of liquid 
isoflurane.  This volume of isoflurane capable of 
being reflected is the equivalent of anesthesia 
maintenance at 1 MAC for 1 hour at a fresh gas 
flow rate of 1 liter per minute. 
 
B. Prototype Device Design 
A prototype was successfully created and could 
perform the basic desired functions.  Specifically, 
inspiratory and expiratory flows were detected and 
a basic “bang-bang” feedback control was 
implemented to achieve the desired concentration. 
Once the charcoal had been saturated from a mock 
anesthesia induction, the controller was able to 
maintain average isoflurane concentrations within 
0.2% by volume of the user set point (1.2% by 
volume). 
 
IV.  DISCUSSION 
 
Activated carbon has been shown to readily absorb 
and release anesthetic gases. Creating a system 
using this material would allow for the 
implementation of an activated carbon reflector 
that absorbs, holds, and releases anesthetic gases 
back to the patient. Not only would this remove the 
need for an anesthetic scavenging system, but it 
would also significantly decrease the cost of 
anesthetic maintenance by reducing the amount of 
gas vaporized. Preliminary data has shown that 40-
mesh activated carbon can capture anesthetic gases 
and release them with reversed flow at a 
concentration high enough for sedation. By 
combining this material with a novel breathing 
circuit design, we will remove the need for a 
scavenging system and expand the environments 
in which anesthesia can be used.   Success in this 
research will ultimately reduce the cost, 
infrastructure, and expertise needed to deliver 
general anesthesia. By doing this, the global access 
to anesthesia and surgical will be greatly 
increased, reducing the suffering in the world. 
Figure 4 The observed concentration of isoflurane leaving the 
vessel containing 40 grams of saturated activated charcoal as the 
flow was reversed at 2 liters per minute. The activated charcoal 
(black) allowed for the gradual released of isoflurane compared to 
the control (red) containing no activated charcoal. 
Figure 5 - The observed concentration of isoflurane during 
ventilation between 10 grams of activated charcoal and the test 
lung. Activated charcoal (grey) allowed for the gradual released of 
isoflurane compared to the control (pink). A running average is 




Future designs will include a dual column system 
that oscillates between a vaporizing column and a 
recovering column (Figure 6).  The system is 
designed so that it can be used with the circle 
breathing system and ventilator of a typical 
anesthesia machine.  In this system one column 
vaporizes anesthetic gas into the fresh gas flow, 
while the other column simultaneously scavenges 
exhaled anesthetic gas from the waste stream.  
When either the vaporizing column begins to 
deplete, or the scavenging column begins to fully 
saturate, a series of valves reverse the roles of each 
column and continue the process indefinitely. A 
fresh gas bypass will also be included to both 
titrate the vaporizing column accordingly and 
allow for pure oxygen delivery when anesthetic 
gas is no longer needed.  A feedback controller 
based off an anesthetic gas concentration sensor at 
the inspiratory limb of the proposed system will 
further control the fresh gas bypass for increased 
accuracy and stability.  By placing the feedback 
sensor in the inspiratory limb, the patient remains 
out of the feedback loop, thereby avoiding 
regulatory hurdles associated with patient-
included feedback control systems like target-
controlled infusion.  If both columns are depleted 
and can no longer maintain set anesthetic gas 
concentrations, a reservoir of anesthetic gas 
separate from the columns will be used to deliver 
anesthetic gas and re-saturate the entire system.    
This system will not require any additional work 
from the clinician as it will be designed to maintain 
an anesthetic gas concentration set by the clinician, 
similar to conventional anesthetic gas vaporizers.  
However, unlike conventional anesthetic gas 
vaporizers, this system limits clinicians to a single 
volatile anesthetic for each case and requires that 
each column be replaced between cases.  While 
there will still be some remaining volatile 
anesthetic gas in each discarded column, the 
overall anesthetic gas used will remain 
substantially lower. 
  
Figure 6 - Schematic of the proposed Scavenging-Vaporizing System and how it functions with a commercial ventilator.  Within the system 
exists two columns alternating in function between vaporizer and scavenger.  These roles are determined through the actuation of valves.  Not 
shown is an anesthetic gas reservoir used if neither column can deliver the set concentration of anesthetic, as well as a fresh gas bypass for 
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